Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous has 4 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Divalproex Sodium, Ganciclovir, Valproic Acid. Patients taking Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 4
- Major
- 3
Major (3)
- Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous + Divalproex Sodium— May decrease divalproex sodium concentrations, increasing risk of breakthrough seizures. Concomitant use should be avoid…
- Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous + Ganciclovir— 7 DRUG INTERACTIONS Ganciclovir: Avoid concomitant use. ( 7.2 ) 7.1 Ganciclovir Generalized seizures have been reported …
- Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous + Valproic Acid— May decrease valproic acid concentrations, increasing risk of breakthrough seizures. Concomitant use should be avoided.